Starting HIV medicine quickly for people in the hospital
Looks at starting HIV medicine during hospital stays and linking adults to care.
Plain-language title generated from the registry record
Registry title: Building Rapid Inpatient Delivery of ART to Generate Engagement in HIV Care
Key facts
- Where
- Chicago, United StatesSee the site
Where in United States
- University of ChicagoChicago, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Chicago
- Trial code
- NCT07847567
- Record updated
- 29 September 2026
- Original description
The study team will pilot rapid antiretroviral therapy (ART) initiation as part of routine inpatient care at the University of Chicago Medicine (UCM), comparing outcomes over a 12-month implementation period. Electronic medical record (EMR) data will be used to evaluate clinical outcomes such as ART initiation within 24-48 hours, linkage to HIV care, retention, and viral suppression, as well as demographic and clinical factors associated with these outcomes. Implementation outcomes will be assessed using Proctor's framework, including acceptability, feasibility, fidelity, and appropriateness.Read full original descriptionShow less
Building Rapid Inpatient Delivery of ART to Generate Engagement in HIV Care (BRIDGE)
The study team will pilot rapid antiretroviral therapy (ART) initiation as part of routine inpatient care at the University of Chicago Medicine (UCM), comparing outcomes over a 12-month implementation period. Electronic medical record (EMR) data will be used to evaluate clinical outcomes such as ART initiation within 24-48 hours, linkage to HIV care, retention, and viral suppression, as well as demographic and clinical factors associated with these outcomes. Implementation outcomes will be assessed using Proctor's framework, including acceptability, feasibility, fidelity, and appropriateness.
Inclusion: 18 years of age or older; Admitted to the UCM General Medicine or Hospital Medicine wards during the study time period; Living with HIV; HIV viral load > 200 copies/mL; Able to speak and understand English; Able and willing to provide informed consent.
Exclusion: Not living with HIV; HIV viral load < 200 copies/mL; Less than 18 years of age; Not admitted to the UCM General Medicine or Hospital Medicine wards during the study time period; Not able to speak and understand English; Unable and/or unwilling to provide informed consent.